290 related articles for article (PubMed ID: 18287869)
21. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
[TBL] [Abstract][Full Text] [Related]
22. CYP1AI, glutathione S-transferase gene polymorphisms and risk of Polycythemia vera.
Naffa RG; Awidi AS; Yousef AM; Ismail SI
Cancer Epidemiol; 2012 Feb; 36(1):68-72. PubMed ID: 22018952
[TBL] [Abstract][Full Text] [Related]
23. Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia.
Bajpai P; Tripathi AK; Agrawal D
Leuk Res; 2007 Oct; 31(10):1359-63. PubMed ID: 17420047
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas.
Trizna Z; de Andrade M; Kyritsis AP; Briggs K; Levin VA; Bruner JM; Wei Q; Bondy ML
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):553-5. PubMed ID: 9641501
[TBL] [Abstract][Full Text] [Related]
25. Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors.
Malik MA; Upadhyay R; Mittal RD; Zargar SA; Mittal B
Nutr Cancer; 2010; 62(6):734-42. PubMed ID: 20661821
[TBL] [Abstract][Full Text] [Related]
26. Association between glutathione S-transferase genotypes and Hodgkin's lymphoma risk and prognosis.
Hohaus S; Massini G; D'Alo' F; Guidi F; Putzulu R; Scardocci A; Rabi A; Di Febo AL; Voso MT; Leone G
Clin Cancer Res; 2003 Aug; 9(9):3435-40. PubMed ID: 12960134
[TBL] [Abstract][Full Text] [Related]
27. Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population.
Rouissi K; Ouerhani S; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB
Cancer Genet Cytogenet; 2009 Apr; 190(2):101-7. PubMed ID: 19380028
[TBL] [Abstract][Full Text] [Related]
28. Cytochrome P4501A1 and glutathione S transferase gene polymorphisms in patients with aplastic anemia in India.
Poonkuzhali B; Shaji RV; Salamun DE; George B; Srivastava A; Chandy M
Acta Haematol; 2005; 114(3):127-32. PubMed ID: 16227674
[TBL] [Abstract][Full Text] [Related]
29. [Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility].
González A; Ramírez V; Cuenca P; Sierra R
Rev Biol Trop; 2004 Sep; 52(3):591-600. PubMed ID: 17361553
[TBL] [Abstract][Full Text] [Related]
30. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms.
Smith GB; Harper PA; Wong JM; Lam MS; Reid KR; Petsikas D; Massey TE
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):839-53. PubMed ID: 11489750
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan.
Wu MS; Chen CJ; Lin MT; Wang HP; Shun CT; Sheu JC; Lin JT
Int J Colorectal Dis; 2002 Sep; 17(5):338-43. PubMed ID: 12172927
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms in the cytochrome P450 1A1, glutathione S-transferase M1 and T1, and susceptibility to colon cancer.
Ye Z; Parry JM
Teratog Carcinog Mutagen; 2002; 22(5):385-92. PubMed ID: 12210502
[TBL] [Abstract][Full Text] [Related]
33. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
34. Combined polymorphism analysis of glutathione S-transferase M1/G1 and interleukin-1B (IL-1B)/interleukin 1-receptor antagonist (IL-1RN) and gastric cancer risk in an Omani Arab Population.
Al-Moundhri MS; Alkindy M; Al-Nabhani M; Al-Bahrani B; Burney IA; Al-Habsi H; Ganguly SS; Tanira M
J Clin Gastroenterol; 2009 Feb; 43(2):152-6. PubMed ID: 18779738
[TBL] [Abstract][Full Text] [Related]
35. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
36. [Genetic and phenotypic polymorphisms in carcinogen-metabolizing enzymes and cancer susceptibility].
Watanabe M
Nihon Rinsho; 1996 Aug; 54(8):2261-75. PubMed ID: 8810806
[TBL] [Abstract][Full Text] [Related]
37. Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia.
Bolufer P; Collado M; Barragan E; Calasanz MJ; Colomer D; Tormo M; González M; Brunet S; Batlle M; Cervera J; Sanz MA
Br J Haematol; 2007 Feb; 136(4):590-6. PubMed ID: 17367411
[TBL] [Abstract][Full Text] [Related]
38. [Genetic polymorphism of gluthation-S transferases and N-acetyl transferases 2 and nasopharyngeal carcinoma: the Tunisia experience].
Bendjemana K; Abdennebi M; Gara S; Jmal A; Ghanem A; Touati S; Boussen H; Ladgham A; Guemira F
Bull Cancer; 2006 Mar; 93(3):297-302. PubMed ID: 16567317
[TBL] [Abstract][Full Text] [Related]
39. Study of genetic polymorphism of xenobiotic enzymes in acute leukemia.
Eyada TK; El Ghonemy EG; El Ghoroury EA; El Bassyouni SO; El Masry MK
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):489-95. PubMed ID: 17581325
[TBL] [Abstract][Full Text] [Related]
40. No association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan.
Cheng YJ; Chien YC; Hildesheim A; Hsu MM; Chen IH; Chuang J; Chang J; Ma YD; Luo CT; Hsu WL; Hsu HH; Huang H; Chang JF; Chen CJ; Yang CS
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):179-80. PubMed ID: 12582034
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
